NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

No, they do not mean the same thing. Off label means not approved, but prescribed by a doctor. Extended label means an official decision by the regulator to add additional indications for a drug.

You’re revealing a profound lack of knowledge, maybe this is not a good investment for you. You really can’t evaluate an investment if basic concepts sound like “word salad” and you are too impatient to do careful due diligence.

As for the investment thesis, my point to you was that under newer laws, regulations and guidance IN the U.S., and other countries, access to new treatments and drugs earlier in the past has been a focus of change. Therefore looking back over 20 years, isn’t going to be fully informative.

But if you prefer to only look backward, that’s a perfectly good way to make decisions. I am not here to tell you to invest here or anywhere else and given your responses, I really don’t think this is for you. You really have to be able to do basic confirmation of basic ideas and facts yourself. You clearly can’t do that. Neither can the other young lady here earlier. These kinds of investments are not really ideal for most people. Try an index. Get a financial advisor. They would not put you in anything like this anyway, just to avoid liability. Investments should be understandable for you or you won’t be able to manage the ups and downs and if you can’t manage those and decide rationally what to do (buy low, sell high, which seems easy, but most people do the opposite even in blue chips), then highly volatile, early stage and risky companies like this are definitely not right.

We are discussing basic recent regulatory efforts and reforms widely discussed in this sector. But you seem unaware and dismissive. So really, try another option.